Skip to content

Comparison of Two Different Treatment Methods

Comparison of Short-term Effects of Two Different Treatment Methods in Patients With Subacromial Impingement Syndrome: a Randomized Controlled Single-blind Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05071469
Enrollment
60
Registered
2021-10-08
Start date
2021-09-28
Completion date
2021-11-30
Last updated
2022-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial Impingement Syndrome, Musculoskeletal Diseases, Musculoskeletal Injury, Musculoskeletal Pain, Weakness, Muscle

Keywords

Subacromial Impingement Syndrome, Mulligan Mobilization Technique, Kinesiotaping, Physiotherapy

Brief summary

A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).

Detailed description

Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.

Interventions

OTHERKinesiotaping

KT was applied.

Sponsors

Muğla Sıtkı Koçman University
CollaboratorOTHER
Banu BAYAR
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Single

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Impingement symptoms in clinical tests * Pain \>1 month

Exclusion criteria

* Any shoulder pathology. * Have chronic systemic diseases or infections. * History of any surgery shoulder complex. * steroid injections and therapeutic approaches

Design outcomes

Primary

MeasureTime frameDescription
Change of pain severityBaseline- after 2 weeks (after treatment)Via VAS.
Change of Range of MotionBaseline- after 2 weeks (after treatment)Via goniometer.
Change of FunctionalityBaseline- after 2 weeks (after treatment)Via SPADI.

Secondary

MeasureTime frameDescription
Change of Sleep QualityBaseline- after 2 weeks (after treatment)Via VAS.
Change of Satisfaction of LifeBaseline- after 2 weeks (after treatment)Via SWLS.
Change of Satisfaction of TreatmentBaseline- after 2 weeks (after treatment)Via VAs.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026